Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...

David Liu and Richard Merkin of the Broad Institute of MIT and Harvard, along with Columbia professor Sam Sternberg, have ...